Zogenix Inc (ZGNX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5959 HORTON STREET, SUITE 500 EMERYVILLE, CA 94608

Zogenix is a global biopharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company's first rare disease therapy, FINTEPLA® (fenfluramine) oral solution has been approved by the U.S. FDA and the European Medicines Agency and is in development in Japan for the treatment of seizures associated with Dravet syndrome, a rare, severe lifelong epilepsy. The company has two additional late-stage development programs underway: one for FINTEPLA for the treatment of seizures associated with Lennox-Gastaut syndrome, another rare epilepsy, and one for MT1621, an investigational therapy for the treatment of a rare genetic disorder called TK2 deficiency. Zogenix is also collaborating with Tevard Biosciences to identify and develop potential next-generation gene therapies for Dravet syndrome and other genetic epilepsies.

Data as of 2021-08-02 08:09:45 -0400
Market Cap904.722 Million Shares Outstanding55.813 Million Avg 30-day Volume923.649 Thousand
P/E Ratio-3.78208 Dividend Yield EPS-4.3
Price/Sales34.69 Debt to Equity1.81 EBITDA-220.399 Million
Price to Book Value2.82 Forward PE-0.36 Enterprise Value620.951 Million
Total Cash435.222 Million Current Debt58.531 Million Gross Profit24.86 Million
BETA0.91333 52-week High/Low25.88 / 15.72 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -17.9498
Data provided by IEX Cloud
View SEC Filings from ZGNX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 1 100.0% 2 (0.12%) 1 (0.06%) 100.0%
Funds Holding: 154 159 -3.14% 54 (3.17%) 62 (3.6%) -12.9%
13F shares: 59.235 Million 58.168 Million 1.83% 30.244 Million 30.306 Million -0.21%
% Ownership 54.2626 54.4357 -0.32%
New Positions: 19 27 -29.63% 6 13 -53.85%
Increased Positions 41 52 -21.15% 12 17 -29.41%
Closed Positions 22 33 -33.33% 14 18 -22.22%
Reduced Positions 58 52 11.54% 28 25 12.0%
Total Calls 1.439 Million 3.479 Million -58.64% 1.186 Million 3.022 Million -60.76%
Total Puts 476.381 Thousand 570.121 Thousand -16.44% 275.1 Thousand 201.4 Thousand 36.59%
PUT/CALL Ratio 0.33 0.16 106.25% 0.23 0.07 228.57%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ZGNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZGNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

3.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SAGROLIKAR ASHISH M EVP & CHIEF COMMERCIAL OFFICER

  • Officer
19,895 2021-07-02 3

TANNENBAUM RENEE P

  • Director
37,872 2021-06-01 3

WAYNICK DENELLE J

  • Director
584 2021-06-01 4

BOCK LOUIS C

  • Director
22,000 2021-05-27 1

MAST ERLE T

  • Director
22,000 2021-05-27 1

GARNER CAM L

  • Director
22,000 2021-05-27 3

WIGGINS MARK C

  • Director
22,000 2021-05-27 1

BREITMEYER JAMES B

  • Director
22,000 2021-05-27 1

LOEWY CAROLINE M

  • Director
22,000 2021-05-27 3

STUTTS MARY E.

  • Director
22,000 2021-05-27 3

FARR STEPHEN J PRESIDENT AND CEO

  • Officer
  • Director
140,000 2021-03-26 2

GALER BRADLEY S. EVP/CHIEF MEDICAL OFFICER

  • Officer
45,000 2021-03-26 2

FARFEL GAIL M EVP/CHIEF DEVELOPMENT OFFICER

  • Officer
45,000 2021-03-26 2

SMITH MICHAEL P EVP, CFO, TREASURER & SEC.

  • Officer
37,500 2021-03-26 2

MITCHELL SHAWNTE EVP, GC AND SECRETARY

  • Officer
37,500 2021-03-26 1

HAWLEY ROGER

  • Director
10,575 2019-03-29 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
No longer subject to file 2018-08-10 0

DARCIS THIERRY J.P. EVP / GENERAL MANAGER, EUROPE

  • Officer
0 2017-03-14 0

RHOADS ANN D EVP, CFO, TREASURER & SEC.

  • Officer
0 2016-03-14 0

SHIVELY RICHARD SCOTT CHIEF COMMERCIAL OFFICER

  • Officer
358,771 2014-06-02 0

BLAIR JAMES C

  • Director
  • 10% Owner
0 2014-05-21 0

ROBINSON CYNTHIA Y CHIEF DEVELOPMENT OFFICER

  • Officer
0 2013-03-15 0

WHEELER KURT

  • Director
  • 10% Owner
0 2012-06-06 0

MINOCHERHOMJEE ARDA PHD

  • Director
0 2012-06-06 0

SCALE VENTURE PARTNERS II, LP

SCALE VENTURE MANAGEMENT II, LLC

MITCHELL KATE

O'DRISCOLL RORY

WIENBAR SHARON L

  • FORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDER
No longer subject to file 2011-09-21 0

HALAK BRIAN K

  • 10% Owner
10,092,586 2011-09-16 0

DOMAIN PARTERS VII L P

  • 10% Owner
9,923,335 2011-09-16 0

DP VII ASSOCIATES LP

  • 10% Owner
169,251 2011-09-16 0

DOVEY BRIAN H

  • 10% Owner
10,092,586 2011-09-16 0

TREU JESSE I

  • 10% Owner
10,092,586 2011-09-16 0

VITULLO NICOLE

  • 10% Owner
10,092,586 2011-09-16 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
10,092,586 2011-09-16 0

CLARUS LIFESCIENCES I, L.P.

CLARUS VENTURES I MANAGEMENT, L.P.

CLARUS VENTURES I, LLC

LIPTAK ROBERT

SIMON NICHOLAS

HENNER DENNIS

GALAKATOS NICHOLAS

WHEELER KURT

STEINMETZ MICHAEL

  • Director
  • 10% Owner
9,482,439 2011-09-16 0

KAMDAR KIM P.

  • 10% Owner
11,000 2011-01-01 0

SCALE VENTURE PARTNERS II, LP

SCALE VENTURE MANAGEMENT II, LLC

BROOKS MARK J

MITCHELL KATE

O'DRISCOLL RORY

WIENBAR SHARON L

  • 10% Owner
4,071,546 2010-11-29 0

DP VI ASSOCIATES, L.P.

  • 10% Owner
106 2010-11-29 0

DOMAIN PARTNERS VI, L.P.

  • 10% Owner
9,894 2010-11-29 0

HAAS KEN

  • Director
2,335,218 2010-11-29 0

THOMAS MCNERNEY & PARTNERS LP

THOMAS, MCNERNEY & PARTNERS, LLC

TMP NOMINEE, LLC

TMP ASSOCIATES LP

THOMAS, MCNERNEY & PARTNERS II L.P.

THOMAS, MCNERNEY & PARTNERS II, LLC

TMP NOMINEE II, LLC

TMP ASSOCIATES II LP

THOMAS JAMES E

MCNERNEY PETE

  • SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)
No longer subject to file 2010-11-29 0

CLARUS LIFESCIENCES I, L.P.

CLARUS VENTURES I, LLC

CLARUS VENTURES I MANAGEMENT, L.P.

LIPTAK ROBERT

SIMON NICHOLAS

HENNER DENNIS

GALAKATOS NICHOLAS

STEINMETZ MICHAEL

  • 10% Owner
5,982,439 2010-11-29 0

CHICAGO GROWTH PARTNERS II L P

CHICAGO GROWTH MANAGEMENT II, LLC

CHICAGO GROWTH MANAGEMENT II, LP

  • SEE REMARKSSEE REMARKSSEE REMARKS
No longer subject to file 2010-11-29 0

DOMAIN ASSOCIATES

  • 10% Owner
11,000 2010-11-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SAGROLIKAR ASHISH M - Officer EVP & CHIEF COMMERCIAL OFFICER

2021-07-06 18:49:10 -0400 2021-07-02 M 3,500 a 17,259 direct 0.0 1.983 1.983 6 0.0 1

SAGROLIKAR ASHISH M - Officer EVP & CHIEF COMMERCIAL OFFICER

2021-07-06 18:49:10 -0400 2021-07-02 M 3,750 d 3,750 direct

SAGROLIKAR ASHISH M - Officer EVP & CHIEF COMMERCIAL OFFICER

2021-07-06 18:49:10 -0400 2021-07-02 F 1,114 $17.74 d 16,145 direct 0.0 1.983 1.983 6 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ZOGENIX INC ZGNX 2021-08-03 15:15:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-03 14:45:04 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-03 14:15:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-03 13:45:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-03 13:15:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-03 12:45:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 22:15:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 21:45:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 21:15:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 20:45:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 20:15:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 19:45:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 19:15:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 18:45:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 18:15:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 17:45:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 17:15:03 UTC -0.3206 0.3806 450000
ZOGENIX INC ZGNX 2021-08-02 16:45:03 UTC -0.3223 0.4023 450000
ZOGENIX INC ZGNX 2021-08-02 16:15:03 UTC -0.3223 0.4023 450000
ZOGENIX INC ZGNX 2021-08-02 15:45:03 UTC -0.3223 0.4023 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund ZGNX -2191.0 shares, $-114216.83 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund ZGNX -1485.0 shares, $-77413.05 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund ZGNX -7439.0 shares, $-297857.56 2019-09-30 N-PORT
American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund ZGNX -23454.0 shares, $-939098.16 2019-09-30 N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund ZGNX -2797.0 shares, $-66204.99 2020-08-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund ZGNX -26.0 shares, $-642.98 2020-03-31 N-PORT
AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund ZGNX -10.0 shares, $-400.4 2019-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund ZGNX -41.0 shares, $-1013.93 2020-03-31 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio ZGNX -6154.0 shares, $-120126.08 2021-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund ZGNX -4471.0 shares, $-87273.92 2021-03-31 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund ZGNX -18720.0 shares, $-365414.4 2021-03-31 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund ZGNX -43263.0 shares, $-844493.76 2021-03-31 N-PORT
FORUM FUNDS- ABSOLUTE CONVERTIBLE ARBITRAGE FUND ZGNX -51600.0 shares, $-1007232.0 2021-03-31 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund ZGNX -10080.0 shares, $-190411.2 2021-04-30 N-PORT
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund ZGNX -31466.0 shares, $-552228.3 2021-05-28 N-PORT

Elevate your investments